🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
33.29
-0.79 (-2.32%)
At close: Nov 20, 2026, 4:00 PM EST
33.31
+0.02 (0.06%)
After-hours: Nov 20, 2026, 7:30 PM EST

Phibro Animal Health Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
102.7199.7248.262.4232.6149.18
Depreciation & Amortization
50.7449.9944.1834.7432.5631.66
Other Amortization
3.893.843.442.482.181.64
Asset Writedown & Restructuring Costs
--5.33---
Loss (Gain) From Sale of Investments
------1.2
Stock-Based Compensation
2.061.60.720.48--
Other Operating Activities
10.688.9-0.2414.37-12.9-4.98
Change in Accounts Receivable
-2.66-7.49-55.21-8.685.34-23.63
Change in Inventory
-94.06-86.34-44.292.64-11.22-47
Change in Accounts Payable
4.43-12.4645.5612-22.8326.36
Change in Other Net Operating Assets
7.9311.232.3927.15-12.42-0.37
Operating Cash Flow
85.7368.9580.1287.5913.3131.65
Operating Cash Flow Growth
11.63%-13.94%-8.53%558.11%-57.95%-34.48%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Capital Expenditures
-64.06-59.09-38.29-41.24-51.79-37.04
Cash Acquisitions
---286.53-3.28--13.51
Investment in Securities
4.93-11.5835-4-2327.35
Other Investing Activities
2.75-0.791.130.330.780.62
Investing Cash Flow
-56.39-71.46-288.69-48.19-74.02-22.58

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Short-Term Debt Issued
-8.417.538.596.36-
Long-Term Debt Issued
-2971,182276326297
Total Debt Issued
368.41305.411,190284.59332.36297
Short-Term Debt Repaid
--7.69-6.56-8.62-1.14-
Long-Term Debt Repaid
--284.25-946.01-263.3-283.32-256.38
Total Debt Repaid
-376.9-291.94-952.57-271.92-284.45-256.38
Net Debt Issued (Repaid)
-8.4913.47236.9612.6747.940.63
Common Dividends Paid
-19.47-19.46-19.45-19.44-19.44-19.44
Other Financing Activities
-0.57-0.57-10.38--1.47-4.84
Financing Cash Flow
-28.53-6.56207.13-6.7726.9916.34

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Foreign Exchange Rate Adjustments
1.962.44-1.14-3.30.75-1.37
Net Cash Flow
2.78-6.62-2.5729.33-32.9724.04

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
21.679.8741.8346.36-38.48-5.4
Free Cash Flow Growth
-36.80%-76.42%-9.76%---
Free Cash Flow Margin
1.41%0.65%3.23%4.55%-3.94%-0.57%
Free Cash Flow Per Share
0.530.241.031.14-0.95-0.13
Levered Free Cash Flow
-4.77-19.3-83.1755.39-33.570.43
Unlevered Free Cash Flow
21.697.4-63.1468.74-22.627.77

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash Income Tax Paid
20.6220.6213.415.4320.4117.85
Change in Working Capital
-84.35-95.1-21.5633.11-41.13-44.64
SEC Filings: 10-K · 10-Q